Ustekinumab
Brand name: Stelara
Rank #19 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$852.3M
Total Cost
31,974
Total Claims
$852.3M
Total Cost
1,173
Prescribers
$27K
Cost per Claim
1,700
Beneficiaries
48,761
30-Day Fills
$727K
Avg Cost/Provider
27
Avg Claims/Provider
Share of Medicare Part D Spending
0.31%
of total Medicare Part D spending
$852.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $852.3M total
🔎 Data Overview
Ranked #19 out of 500 drugs tracked by total cost. Ustekinumab represents a significant portion of Medicare drug spending.
At $26,655 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $726,583 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $501,343 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Ustekinumab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Donna Ortiz | Nurse Practitioner | Orlando, FL | 464 | $12.6M |
| 2 | Sarah Glover | Osteopathic Manipulative Medicine | Jackson, MS | 275 | $7.6M |
| 3 | Kelly Bireley | Nurse Practitioner | Angola, IN | 237 | $6.7M |
| 4 | Melissa Garrett | Gastroenterology | Fort Wayne, IN | 224 | $6.3M |
| 5 | Andrea Banty | Nurse Practitioner | West Hollywood, CA | 199 | $5.7M |
| 6 | Frederick Weber | Gastroenterology | Birmingham, AL | 210 | $5.5M |
| 7 | Nitin Gupta | Gastroenterology | Atlanta, GA | 195 | $5.4M |
| 8 | Udayakumar Navaneethan | Gastroenterology | Saint Petersburg, FL | 209 | $5.3M |
| 9 | Ashwin Ananthakrishnan | Gastroenterology | Boston, MA | 178 | $5.0M |
| 10 | Kristen Boardman | Physician Assistant | Ann Arbor, MI | 178 | $4.9M |
| 11 | Alexandra Gutierrez | Gastroenterology | New York, NY | 177 | $4.8M |
| 12 | Richard Bloomfeld | Gastroenterology | Winston Salem, NC | 166 | $4.7M |
| 13 | Richard Rood | Gastroenterology | Saint Louis, MO | 164 | $4.6M |
| 14 | Andrew Dupont | Gastroenterology | Houston, TX | 131 | $4.5M |
| 15 | Terrence Barrett | Gastroenterology | Lexington, KY | 169 | $4.4M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 16 | Mirabegron (Myrbetriq) | $927.5M | 1,407,073 |
| 17 | Tirzepatide (Mounjaro) | $877.9M | 680,457 |
| 18 | Ibrutinib (Imbruvica) | $875.8M | 56,368 |
| 19 | Ustekinumab (Stelara) | $852.3M | 31,974 |
| 20 | Paliperidone Palmitate (Invega Sustenna) | $832.3M | 252,388 |
| 21 | Insulin Aspart (Novolog Flexpen) | $831.6M | 958,823 |
| 22 | Budesonide/Formoterol Fumarate (Symbicort) | $759.4M | 1,452,561 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology